Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India
Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India
Natco Phrama launched the drug for the treatment of Hepatitis C Virus. It is a fixed combination of Sofosbuvir-Daclatasvir tablets under the brand name of Hepcinat Plus in India.
The product is a generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg tablets used for the treatment of patients with chronic Hepatitis C virus infection, the company said in a filing to the BSE.
Natco Phrama has launched Hepnicat Plus Tablet at the price of Rs. 17,500; it contains a bottle of 28 tablets.
Hepcinat Plus (Sofosbuvir & Daclatasvir) Details:
Brand Name: Hepcinat Plus
Composition: Sofosbuvir 400mg & Daclatasvir 60mg
Manufactured by: Natco Pharma Ltd.
Packing: Pack of 28 Tablets
Country of Origin: India
